Woods M L, Koch C J, Lord E M
Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Int J Radiat Oncol Biol Phys. 1996 Jan 1;34(1):93-101. doi: 10.1016/0360-3016(95)02006-3.
The purpose of this work was to evaluate EF5, a 2-nitroimidazole compound, and anti-EF5 antibodies as a method to quantify radiobiologically hypoxic cells.
Multicellular spheroids of EMT6 mammary sarcoma cells were used as a model to identify hypoxic cells that were resistant to radiation damage. This was accomplished by incubating the spheroids with the 2-nitroimidazole (EF5), which forms hypoxia-dependent adducts with cellular macromolecules that are detected by fluorescent monoclonal antibodies.
Cells from spheroids grown for 2 days in sealed flasks had an increased surviving fraction following radiation as compared to fully reoxygenated spheroids, indicating the presence of radiobiological hypoxia. Treatment of the spheroids with EF5 and subsequent immunohistochemical staining of cryosections with an anti-EF5 fluorochrome conjugated monoclonal antibody allowed for the identification of EF5-adduct containing cells. Spheroids grown under hypoxic conditions in the presence of EF5 showed limited staining of the peripheral cell layers, intense staining of the interior, and an absence of staining within the necrotic center. In contrast, there was minimal staining in reoxygenated spheroids and no staining in control spheroids incubated in the absence of EF5. Flow cytometric analysis of single cells dissociated from spheroids allowed for the calculation of the percentage of stained cells, as well as the intensity of staining. A comparison of the intensity of staining of EF5 treated hypoxic spheroids with the intensity of staining of single cells incubated with EF5 under controlled oxygen concentrations was used to estimate the oxygen concentration range within spheroids. Selective dissociation of spheroids provided a direct demonstration that the cells containing the highest level of EF5 binding were also the cells with increased radiation resistance.
This technique provides an excellent means of detecting and quantifying hypoxia, which should be directly applicable in tumors.
本研究旨在评估2-硝基咪唑化合物EF5及抗EF5抗体作为一种定量放射生物学低氧细胞的方法。
采用EMT6乳腺肉瘤细胞的多细胞球体作为模型,以识别对辐射损伤具有抗性的低氧细胞。这是通过将球体与2-硝基咪唑(EF5)孵育来实现的,EF5与细胞大分子形成依赖低氧的加合物,可通过荧光单克隆抗体进行检测。
与完全复氧的球体相比,在密封烧瓶中培养2天的球体中的细胞在辐射后存活分数增加,表明存在放射生物学低氧。用EF5处理球体,随后用抗EF5荧光染料偶联的单克隆抗体对冰冻切片进行免疫组织化学染色,可识别含有EF5加合物的细胞。在低氧条件下于EF5存在时生长的球体,外周细胞层染色有限,内部染色强烈,坏死中心无染色。相比之下,复氧球体染色最少,在无EF5孵育的对照球体中无染色。对从球体解离的单细胞进行流式细胞术分析,可计算染色细胞的百分比以及染色强度。将EF5处理的低氧球体的染色强度与在受控氧浓度下用EF5孵育的单细胞的染色强度进行比较,以估计球体内的氧浓度范围。球体的选择性解离直接证明,含有最高水平EF5结合的细胞也是辐射抗性增加的细胞。
该技术为检测和定量低氧提供了一种极好的方法,应可直接应用于肿瘤。